遠東股份(600869.SH):遠東控股已向國遠投資轉讓2%股份
格隆匯9月8日丨遠東股份(600869.SH)公佈,2021年9月7日,遠東控股與國遠投資就股份轉讓事宜中的每股轉讓價格、轉讓數量等簽署了《股份轉讓補充協議》,協議轉讓的每股交易價格為5.53元,轉讓股數為117,192,892股(佔公司總股本5.28%);大宗交易的每股交易價格為5.67元,轉讓股數為44,387,000股(佔公司總股本2.00%)。
2021年9月8日,遠東控股通過大宗交易方式向國遠投資轉讓其所持有的公司股份4438.7萬股(佔公司總股本的2.00%),轉讓價格為5.67元/股。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.